LncRNA FAM138B inhibits the progression of non-small cell lung cancer through miR-105-5p

References

• Li X, Yuan N, Lin L, et al. Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer. Exp Ther Med. 2018 Aug;16(2):730–738.
   PubMed Web of Science ®Google Scholar
• Dang X, Zhao W, Li C, et al. Impact of COL6A4P2 gene polymorphisms on the risk of lung cancer: a case-control study. PLoS ONE. 2021;16(5):e0252082. DOI:10.1371/journal.pone.0252082
   PubMed Web of Science ®Google Scholar
• Ding CZ, Guo XF, Wang GL, et al. High glucose contributes to the proliferation and migration of non-small cell lung cancer cells via GAS5-TRIB3 axis. Biosci Rep. 2018 Jan 24;38(2). DOI:10.1042/BSR20171014
   Google Scholar
• Yu F, Xiao R, Li X, et al. Combined effects of lung disease history, environmental exposures, and family history of lung cancer to susceptibility of lung cancer in Chinese non-smokers. Respir Res. 2021 Jul 23;22(1):210. DOI:10.1186/s12931-021-01802-z
   PubMed Web of Science ®Google Scholar
• Wen P, Chidanguro T, Shi Z, et al. Identi?cation of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. Mol Med Rep. 2018 Aug;18(2):1538–1550.
   PubMed Web of Science ®Google Scholar
• Monkam P, Qi S, Xu M, et al. CNN models discriminating between pulmonary micro-nodules and non-nodules from CT images. Biomed Eng Online. 2018 Jul 16;17(1):96. DOI:10.1186/s12938-018-0529-x
   PubMedGoogle Scholar
• Collins LG, Haines C, Perkel R, et al. Lung cancer: diagnosis and management. Am Fam Physician. 2007 Jan 1;75(1):56–63.
   PubMed Web of Science ®Google Scholar
• Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008 May;83(5):584–594.
   PubMed Web of Science ®Google Scholar
• Sun W, Zhang L, Yan R, et al. LncRNA DLX6-AS1 promotes the proliferation, invasion, and migration of non-small cell lung cancer cells by targeting the miR-27b-3p/gspt1 axis. Onco Targets Ther. 2019;12:3945–3954.
   PubMedGoogle Scholar
• Wei T, Cheng S, Fu XN, et al. miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164. Biosci Rep. 2020 Jul 31;40(7). DOI:10.1042/BSR20192795
   Google Scholar
• Zhen Q, Gao LN, Wang RF, et al. LncRNA DANCR promotes lung cancer by sequestering miR-216a. Cancer Control. 2018 Jan-Mar;25(1):1073274818769849.
   Web of Science ®Google Scholar
• Jiang N, Meng X, Mi H, et al. Circulating lncRNA XLOC_009167 serves as a diagnostic biomarker to predict lung cancer. Clin Chim Acta. 2018 Nov;486:26–33.
   PubMed Web of Science ®Google Scholar
• Zhang YX, Yuan J, Gao ZM, et al. LncRNA TUC338 promotes invasion of lung cancer by activating MAPK pathway. Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):443–449.
   PubMed Web of Science ®Google Scholar
• Li X, Li B, Ran P, et al. Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma. Oncol Lett. 2018 Nov;16(5):5697–5708.
   PubMed Web of Science ®Google Scholar
• Mao Y, Yang D, He J, et al. Epidemiology of lung cancer. Surg Oncol Clin N Am. 2016 Jul;25(3):439–445.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Canales J, Parra-Cuentas E, Wistuba II. Diagnosis and molecular classification of lung cancer. Cancer Treat Res. 2016;170:25–46.
   PubMedGoogle Scholar
• Loewen G, Jayawickramarajah J, Zhuo Y, et al. Functions of lncRNA HOTAIR in lung cancer. Journal of Hematology & Oncology. 2014 Dec 10;7(1):90. DOI:10.1186/s13045-014-0090-4
   PubMedGoogle Scholar
• Zhang J, Zhou N, Lin A, et al. ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer. Cancer Immunol Immunother. 2021 Jan;70(1):137–151.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Shi H, Du Y, et al. lncRNA DLEU2 modulates cell proliferation and invasion of non-small cell lung cancer by regulating miR-30c-5p/sox9 axis. Aging. 2019 Sep 20;11(18):7386–7401. DOI:10.18632/aging.102226
   PubMedGoogle Scholar
• Xu S, Zhai S, Du T, et al. LncRNA MIR503HG inhibits non-small cell lung cancer cell proliferation by inducing cell cycle arrest through the downregulation of cyclin D1. Cancer Manage Res. 2020;12:1641–1647.
   PubMed Web of Science ®Google Scholar
• Ginn L, Shi L, Montagna M, et al. LncRnas in non-small-cell lung cancer. Noncoding RNA. 2020 Jun 30;6(3):25. DOI:10.3390/ncrna6030025
   PubMed Web of Science ®Google Scholar
• Chen W, Lu Q, Li S, et al. microRNA-1298 inhibits the malignant behaviors of breast cancer cells via targeting ADAM9. Biosci Rep. 2020 Dec 23;40(12). DOI:10.1042/BSR20201215
   Google Scholar
• Chen T, Liu Y, Chen J, et al. Exosomal miR-3180-3p inhibits proliferation and metastasis of non-small cell lung cancer by downregulating FOXP4. Thoracic Cancer. 2021 Feb;12(3):372–381.
   PubMed Web of Science ®Google Scholar
• Cui J, Pan G, He Q, et al. MicroRNA-545 targets ZEB2 to inhibit the development of non-small cell lung cancer by inactivating Wnt/β-catenin pathway. Oncol Lett. 2019 Sep;18(3):2931–2938.
   PubMed Web of Science ®Google Scholar
• Cui G, Cui M, Li Y, et al. MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells. Tumour Biol. 2014 Sep;35(9):8933–8937.
   PubMedGoogle Scholar
• Lu W, Zhang H, Niu Y, et al. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Mol cancer. 2017 Jul 11;16(1):118. DOI:10.1186/s12943-017-0685-9
   PubMedGoogle Scholar
• Dong X, Chang M, Song X, et al. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer. Thoracic Cancer. 2021 Feb;12(4):539–548.
   PubMed Web of Science ®Google Scholar
• Sun F, Yang X, Jin Y, et al. Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using the cancer genome atlas expression data. Mol Med Rep. 2017 Jul;16(1):609–616.
   PubMed Web of Science ®Google Scholar
• Miliotis C, Slack FJ. miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer. Cancer Lett. 2021 Oct 10;518:115–126. DOI:10.1016/j.canlet.2021.05.037.
   PubMed Web of Science ®Google Scholar
• He B, Zhang K, Han X, et al. Extracellular vesicle-derived miR-105-5p Promotes Malignant Phenotypes of Esophageal Squamous Cell Carcinoma by targeting SPARCL1 via FAK/AKT signaling pathway. Front genet. 2022;13:819699.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhu S, Tao Z, et al. High circulating miR-18a, miR-20a, and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer. Cancer Med. 2018 Jan;7(1):21–31.
   PubMed Web of Science ®Google Scholar
• Deng F, Yang K. Current status of research on the period family of clock genes in the occurrence and development of cancer. J Cancer. 2019;10(5):1117–1123.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chi B, Chai J, et al. LncRNA CCDC144NL-AS1 serves as a prognosis biomarker for non-small cell lung cancer and promotes cellular function by targeting miR-490-3p. Mol Biotechnol. 2021 Jun 11;63(10):933–940. DOI:10.1007/s12033-021-00351-6
   PubMed Web of Science ®Google Scholar
• Wu W, Zhao Y, Gao E, et al. LncRNA DLEU2 accelerates the tumorigenesis and invasion of non-small cell lung cancer by sponging miR-30a-5p. J Cell Mol Med. 2020 Jan;24(1):441–450.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Qiao W, Wang X, et al. 14-3-3ζ/TGFβR1 promotes tumor metastasis in lung squamous cell carcinoma. Oncotarget. 2016 Dec 13;7(50):82972–82984. DOI:10.18632/oncotarget.12690
   PubMedGoogle Scholar